Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Amlodipine + indapamide is a fixed-dose combination medication used primarily for the treatment of hypertension (high blood pressure). It combines two active pharmaceutical ingredients with complementary mechanisms of action. Amlodipine is a calcium channel blocker that relaxes blood vessels, making it easier for the heart to pump blood and thereby lowering blood pressure. Indapamide is a thiazide-like diuretic that increases urine production by inhibiting sodium reabsorption in the kidneys, leading to removal of excess water and electrolytes from the body, which also helps reduce blood pressure. This combination provides an effective antihypertensive therapy by targeting different physiological pathways involved in blood pressure regulation[1][4][5][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on amlodipine + indapamide.